Clinical Trials Browser

Phase 2 × Carcinoma, Ovarian Epithelial × Neoadjuvant Therapy × Clear all

NCT02124421 2024-11-19

CRS/HIPEC

Phase 2 Active not recruiting

Carcinoma, Ovarian Epithelial, Fallopian Tube Neoplasms, Ovarian Neoplasms